speb/financial-data huggingface dataset:
GRN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -5505000.00
GRN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -5505000.00
GRN.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -5505000.00
GRN.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -5505000.00
GRN.TO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
GRN.TO income_statement (annual, 2022-12-31) — Net Interest Income: 250000.00
GRN.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -309000.00
GRN.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -309000.00
GRN.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 250000.00
GRN.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1584000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Net PPE: 1732000.00
GRN.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -515000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 27052000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 448000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 2318000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 448000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 736000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 1752000.00
GRN.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -4676000.00
GRN.TO income_statement (annual, 2022-12-31) — Normalized Income: -6706301.20
GRN.TO balance_sheet (annual, 2022-12-31) — Notes Receivable: 0.00
GRN.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 40000.00
GRN.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -2167000.00
GRN.TO income_statement (annual, 2022-12-31) — Operating Income: -7330000.00
GRN.TO income_statement (annual, 2022-12-31) — Operating Revenue: 71241000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 152040781.00
GRN.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 1266000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1062000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -378000.00
GRN.TO income_statement (annual, 2022-12-31) — Other Gand A: 5924000.00
GRN.TO income_statement (annual, 2022-12-31) — Other Income Expense: 1591000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 8349000.00
GRN.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -213000.00
GRN.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -37000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Other Properties: 2113000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 15269000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Payables: 4454000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 22982000.00
GRN.TO income_statement (annual, 2022-12-31) — Pretax Income: -5489000.00
GRN.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 78000.00
GRN.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -7813000.00
GRN.TO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
GRN.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -515000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 1129000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Receivables: 27554000.00
GRN.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 54429000.00
GRN.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2332000.00
GRN.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -309000.00
GRN.TO income_statement (annual, 2022-12-31) — Research And Development: 1061000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Restricted Cash: 1694000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -15672000.00
GRN.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 11878000.00
GRN.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1944000.00
GRN.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 20749000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Share Issued: 152040781.00
GRN.TO income_statement (annual, 2022-12-31) — Special Income Charges: -539000.00
GRN.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1977000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 53483000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 27052000.00
GRN.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 426698.80
GRN.TO income_statement (annual, 2022-12-31) — Tax Provision: 16000.00
GRN.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
GRN.TO balance_sheet (annual, 2022-12-31) — Total Assets: 83387000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 53483000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Debt: 1235000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 53483000.00
GRN.TO income_statement (annual, 2022-12-31) — Total Expenses: 78571000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 29904000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 30363000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4123000.00
GRN.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -7869000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 510000.00
GRN.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 1628000.00
GRN.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1628000.00
GRN.TO balance_sheet (annual, 2022-12-31) — Working Capital: 27243000.00
GRN.TO income_statement (annual, 2022-12-31) — Write Off: 539000.00
GRN.TO income_statement (annual, 2023-12-31) — +Operating Expense: 22387000.00
GRN.TO income_statement (annual, 2023-12-31) — +Total Revenue: 54633000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 3094000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 9804000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2027000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4893000.00
GRN.TO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1775000.00
GRN.TO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 1775000.00
GRN.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 14352000.00
GRN.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 153067660.00
GRN.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.19
GRN.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 21381000.00
GRN.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -197000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1951000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 65814000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 11790000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 11790000.00
GRN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -182000.00
GRN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -311000.00
GRN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -7644000.00
GRN.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: -83000.00
GRN.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 0.00
GRN.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -1355000.00
GRN.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -818000.00
GRN.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 2058000.00
GRN.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3213000.00
GRN.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -474000.00
GRN.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 4109000.00
GRN.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 1662000.00
GRN.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 2458000.00
GRN.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -9575000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Common Stock: 65814000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 25302000.00
GRN.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 42978000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 16557000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Assets: 41370000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 232000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 232000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 3615000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 3615000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 24688000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 1190000.00
GRN.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 373000.00
GRN.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 373000.00
GRN.TO cash_flow (annual, 2023-12-31) — Depreciation: 517000.00
GRN.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2292000.00
GRN.TO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 342000.00
GRN.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2292000.00
GRN.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 342000.00
GRN.TO income_statement (annual, 2023-12-31) — Depreciation Income Statement: 342000.00
GRN.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 153067660.00
GRN.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.19
GRN.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -29580000.00
GRN.TO income_statement (annual, 2023-12-31) — EBIT: -27345000.00
GRN.TO income_statement (annual, 2023-12-31) — EBITDA: -25053000.00
GRN.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -16000.00
GRN.TO cash_flow (annual, 2023-12-31) — End Cash Position: 11790000.00
GRN.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -265000.00
GRN.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -9196000.00
GRN.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -290000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -153000.00
GRN.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 19806000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Goodwill: 7780000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 10610000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 9804000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 4402000.00
GRN.TO income_statement (annual, 2023-12-31) — Gross Profit: 11655000.00
GRN.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 14352000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 87000.00
GRN.TO income_statement (annual, 2023-12-31) — Insurance And Claims: 1003000.00
GRN.TO income_statement (annual, 2023-12-31) — Interest Expense: 79000.00
GRN.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 79000.00
GRN.TO income_statement (annual, 2023-12-31) — Interest Income: 651000.00
GRN.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 651000.00
GRN.TO cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -76000.00
GRN.TO cash_flow (annual, 2023-12-31) — Interest Received Cfo: 546000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Inventory: 2063000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 25302000.00
GRN.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -311000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1719000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1719000.00
GRN.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -219000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 200000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1264000.00
GRN.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
GRN.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 290000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income: -29580000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -29580000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -28526000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -1054000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -29580000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -28526000.00
GRN.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -28526000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -29580000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Interest Income: 572000.00
GRN.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -219000.00
GRN.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -219000.00
GRN.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 572000.00
GRN.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -114000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Net PPE: 2375000.00
GRN.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -197000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 14692000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
GRN.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2446000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
GRN.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 669000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 0.00
GRN.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -7961000.00
GRN.TO income_statement (annual, 2023-12-31) — Normalized Income: -18270800.00
GRN.TO balance_sheet (annual, 2023-12-31) — Notes Receivable: 859000.00
GRN.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -8999000.00
GRN.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 290000.00
GRN.TO income_statement (annual, 2023-12-31) — Operating Income: -10732000.00
GRN.TO income_statement (annual, 2023-12-31) — Operating Revenue: 54633000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 153790399.00
GRN.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 1665000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -153000.00
GRN.TO income_statement (annual, 2023-12-31) — Other Gand A: 6300000.00
GRN.TO income_statement (annual, 2023-12-31) — Other Income Expense: -17264000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2830000.00
GRN.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -400000.00
GRN.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -172000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Other Properties: 3138000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 13586000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Payables: 3094000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 19651000.00
GRN.TO income_statement (annual, 2023-12-31) — Pretax Income: -27424000.00
GRN.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 37000.00
GRN.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
GRN.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -197000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 2063000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Receivables: 24249000.00
GRN.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 41028000.00
GRN.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2292000.00
GRN.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -219000.00
GRN.TO income_statement (annual, 2023-12-31) — Research And Development: 681000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Restricted Cash: 1603000.00
GRN.TO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
GRN.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -45252000.00
GRN.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 12503000.00
GRN.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
GRN.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1558000.00
GRN.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 21364000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Share Issued: 153790399.00
GRN.TO income_statement (annual, 2023-12-31) — Special Income Charges: -16802000.00
GRN.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 775000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 25302000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 14692000.00
GRN.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -6836800.00
GRN.TO income_statement (annual, 2023-12-31) — Tax Provision: 1102000.00
GRN.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.40
GRN.TO balance_sheet (annual, 2023-12-31) — Total Assets: 54355000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 25302000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Debt: 1951000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 25302000.00
GRN.TO income_statement (annual, 2023-12-31) — Total Expenses: 65365000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 29053000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 12985000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 4365000.00
GRN.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -12114000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 87000.00
GRN.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -17092000.00
GRN.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -17092000.00
GRN.TO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 1068000.00
GRN.TO balance_sheet (annual, 2023-12-31) — Working Capital: 16682000.00
GRN.TO income_statement (annual, 2023-12-31) — Write Off: 2450000.00
GRN.TO cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 952000.00
GRN.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 154189618.00
GRN.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.01
GRN.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 154189618.00
GRN.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.01
GRN.TO cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
GRN.TO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
GRN.TO cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
GRN.TO cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
GRN.TO income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 518000.00
GRN.TO cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
GRN.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: -1470000.00
GRN.TO income_statement (quarterly, 2024-09-30) — Write Off: 952000.00
GRN.TO income_statement (annual, 2024-12-31) — +Operating Expense: 18439000.00
GRN.TO income_statement (annual, 2024-12-31) — +Total Revenue: 51820000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 2900000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 6945000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2154000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 5054000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1099000.00
GRN.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1099000.00
GRN.TO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 565000.00
GRN.TO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 565000.00
GRN.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -952000.00
GRN.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 154330595.00
GRN.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.01
GRN.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 11790000.00
GRN.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -75000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2074000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 66097000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 16168000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 16168000.00
GRN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -251000.00
GRN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -53000.00
GRN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 5330000.00
GRN.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: -27000.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
GRN.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
GRN.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -713000.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
GRN.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 1200000.00
GRN.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 1629000.00
GRN.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -7591000.00
GRN.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 679000.00
GRN.TO cash_flow (annual, 2024-12-31) — Change In Receivables: 12397000.00
GRN.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 8314000.00
GRN.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 3540000.00
GRN.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 4286000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Common Stock: 66097000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 23975000.00
GRN.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 36386000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7821000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Assets: 32842000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 328000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 328000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 6716000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 6069000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 18601000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 836000.00
GRN.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 782000.00
GRN.TO cash_flow (annual, 2024-12-31) — Deferred Tax: 782000.00
GRN.TO cash_flow (annual, 2024-12-31) — Depreciation: 545000.00
GRN.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1110000.00
GRN.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 215000.00
GRN.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1110000.00
GRN.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 215000.00
GRN.TO income_statement (annual, 2024-12-31) — Depreciation Income Statement: 215000.00
GRN.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 154330595.00
GRN.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
GRN.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -1863000.00
GRN.TO income_statement (annual, 2024-12-31) — EBIT: -455000.00
GRN.TO income_statement (annual, 2024-12-31) — EBITDA: 655000.00
GRN.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 92000.00
GRN.TO cash_flow (annual, 2024-12-31) — End Cash Position: 16168000.00
GRN.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -278000.00
GRN.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 4542000.00
GRN.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 1261000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -61000.00
GRN.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 16875000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Goodwill: 7949000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 10272000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 8044000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 4392000.00
GRN.TO income_statement (annual, 2024-12-31) — Gross Profit: 15434000.00
GRN.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
GRN.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
GRN.TO balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 0.00
GRN.TO income_statement (annual, 2024-12-31) — Insurance And Claims: 931000.00
GRN.TO income_statement (annual, 2024-12-31) — Interest Expense: 143000.00
GRN.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 143000.00
GRN.TO income_statement (annual, 2024-12-31) — Interest Income: 467000.00
GRN.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 467000.00
GRN.TO cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -143000.00
GRN.TO cash_flow (annual, 2024-12-31) — Interest Received Cfo: 333000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Inventory: 819000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 23975000.00
GRN.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -53000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1746000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1746000.00
GRN.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -251000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1158000.00
GRN.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 22000.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
GRN.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -1261000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income: -1863000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -1863000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -1380000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -483000.00
GRN.TO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1863000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1380000.00
GRN.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -1380000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -1863000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Interest Income: 324000.00
GRN.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -251000.00
GRN.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -251000.00
GRN.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 324000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Net PPE: 2238000.00
GRN.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -75000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 13703000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1030000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 383000.00
GRN.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -192000.00
GRN.TO income_statement (annual, 2024-12-31) — Normalized Income: -2099950.00
GRN.TO balance_sheet (annual, 2024-12-31) — Notes Receivable: 1607000.00
GRN.TO balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 1607000.00
GRN.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 4617000.00
GRN.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1261000.00
GRN.TO income_statement (annual, 2024-12-31) — Operating Income: -3005000.00
GRN.TO income_statement (annual, 2024-12-31) — Operating Revenue: 51820000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 156690024.00
GRN.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 933000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -61000.00
GRN.TO income_statement (annual, 2024-12-31) — Other Gand A: 5185000.00
GRN.TO income_statement (annual, 2024-12-31) — Other Income Expense: 2083000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2323000.00
GRN.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -837000.00
GRN.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1236000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Other Properties: 3234000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 4258000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Payables: 2900000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 10721000.00
GRN.TO income_statement (annual, 2024-12-31) — Pretax Income: -598000.00
GRN.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
GRN.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
GRN.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -75000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 819000.00
GRN.TO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 819000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Receivables: 12810000.00
GRN.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 35491000.00
GRN.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1110000.00
GRN.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -251000.00
GRN.TO income_statement (annual, 2024-12-31) — Research And Development: 411000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Restricted Cash: 2112000.00
GRN.TO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 648000.00
GRN.TO income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 130000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -47115000.00
GRN.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 10759000.00
GRN.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 22000.00
GRN.TO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
GRN.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 938000.00
GRN.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 17813000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Share Issued: 156690024.00
GRN.TO income_statement (annual, 2024-12-31) — Special Income Charges: -414000.00
GRN.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 1056000.00
GRN.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 444000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 23975000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 13703000.00
GRN.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 127050.00
GRN.TO income_statement (annual, 2024-12-31) — Tax Provision: 782000.00
GRN.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
GRN.TO cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -1501000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Assets: 45352000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 23975000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Debt: 2074000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 23975000.00
GRN.TO income_statement (annual, 2024-12-31) — Total Expenses: 54825000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 21377000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 12510000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2776000.00
GRN.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3950000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
GRN.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
GRN.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 847000.00
GRN.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 847000.00
GRN.TO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -531000.00
GRN.TO balance_sheet (annual, 2024-12-31) — Working Capital: 14241000.00
GRN.TO income_statement (annual, 2024-12-31) — Write Off: -234000.00
GRN.TO income_statement (quarterly, 2024-12-31) — Write Off: -1186000.00
GRN.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 3994000.00
GRN.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 7007000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2983000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6271000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2311000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5112000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 144000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 144000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 156816135.00
GRN.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
GRN.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 16168000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -31000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2032000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 66111000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 16200000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 16200000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -81000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 891000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -966000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Financing Activities: 0.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 0.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -443000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 1129000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -699000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -380000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 583000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 28000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 243000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -156000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 66111000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 23064000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4428000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 7351000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 31630000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 339000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 339000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 8190000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 7505000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19196000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 333000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 124000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 124000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 129000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 273000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 54000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 273000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 54000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 54000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 156816135.00
GRN.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
GRN.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — EBIT: -859000.00
GRN.TO income_statement (quarterly, 2025-03-31) — EBITDA: -586000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 188000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 16200000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -81000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -997000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 488000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -29000.00
GRN.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3527000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 8243000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 10504000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 6271000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4497000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 2579000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 32000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 32000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Interest Income: 94000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 94000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -32000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 94000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 1261000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 23064000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 891000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1693000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1693000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -81000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1214000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -488000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Income: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1015000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1015000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 62000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -81000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -81000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 62000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 922000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 2186000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -31000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 12560000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 367000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 367000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1074000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -1429800.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 0.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -966000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -488000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Operating Income: -1415000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 7007000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 156840024.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1313000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -29000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 3455000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 462000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2261000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -36000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -26000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 3283000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4848000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Payables: 2983000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10334000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -891000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -31000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 11119000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4209000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 273000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -81000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Research And Development: 253000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1737000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -48130000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 72000.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
GRN.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 160000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3687000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 156840024.00
GRN.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 72000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 23064000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 12560000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 73200.00
GRN.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 124000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
GRN.TO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 14000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 44320000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 23064000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 2032000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 23064000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 8422000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 21256000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12690000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2060000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1415000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 488000.00
GRN.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 488000.00
GRN.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 12434000.00
GRN.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 4162000.00
GRN.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 15077000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3710000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 10143000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2471000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5237000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1333000.00
GRN.TO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 150000.00
GRN.TO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 150000.00
GRN.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 156918991.00
GRN.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
GRN.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 16200000.00
GRN.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -60000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2564000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 66120000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 16606000.00
GRN.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 16606000.00